Project Grant P20GM156711
Award Date
6/10/25
Completion Date
4/30/30
Dollars Obligated
$2.5M
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $470,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Institute For Cancer Research, a non-profit subsidiary of Temple University, for a 5-year research project starting on September 17, 2024. The goal of the project is to characterize the molecular-level interactions and coordination events coupling the repair of oxidative DNA damage and gene enhancement at G-quadruplex promoter regions in...
The National Institute of General Medical Sciences (NIGMS) awarded a $445,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Beckman Research Institute of the City of Hope. The grant, effective February 1, 2025 through January 31, 2030, supports research projects focused on understanding the structural basis and allosteric modulation of G protein-coupled receptor (GPCR) interactions with G proteins. Key objectives include: Dissecting the structural...
This federal Project Grant award, R35GM153238, is funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The $890,066 award, effective from Sep 2, 2024 to Jul 31, 2029, supports research to identify the genetic instructions and processes that regulate long-distance interactions between enhancers and promoters, which are critical for controlling gene expression patterns during embryonic development and in...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant (CFDA 93.859 - Biomedical Research and Research Training) totaling $667,480 to St. Jude Children's Research Hospital Inc. The grant, which runs from May 1, 2025 to April 30, 2030, supports research to understand the dynamics of active and silent chromatin states, including the biology of repetitive elements and the mechanisms of chromatin dynamics and modifications. The research combines structural biology,...
This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
This $390,000 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will support the development of innovative proteomic technologies to study transcription factor-coregulator interactions. The award aims to pioneer DNA barcode-based methods that can enhance the specificity and reproducibility of existing techniques like mass spectrometry-based RIME for characterizing epigenetic...
The National Institute of General Medical Sciences (NIGMS) awarded a $528,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Sloan-Kettering Institute for Cancer Research located in New York, NY. The purpose of this 4-year grant, with a period of performance from September 30, 2024 to July 31, 2028, is to develop novel approaches to map the folding and protein occupancy of entire chromosomes with single-nucleosome resolution and single-molecule precision. The...
This $1,072,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to advance cancer research in Oklahoma. The award supports the COBRE (Center of Biomedical Research Excellence) program, which has demonstrated remarkable progress in Phases I and II, with COBRE-supported researchers securing highly competitive grants and publishing 246 papers benefiting from COBRE resources. For Phase III, the...
The National Institute of General Medical Sciences (NIGMS) awarded a $294,647 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Texas at Dallas (UTD). The grant will fund a 4-year project from September 1, 2024 to August 31, 2028 to develop a theoretical, computational, and experimental framework for modeling epigenetic regulatory networks in human cells. The key objectives are to rapidly assemble and stably integrate libraries of...
This $1,449,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research to study the fundamental regulation of extrachromosomal DNA (ecDNA) in cancer genomes. The project aims to develop new live-cell chromatin labeling strategies and integrate advanced imaging, synthetic genome engineering, and optical/genetic perturbation to systematically investigate how ecDNA orchestrates massive...